Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
0.256 %
$ 349 M
Market Cap
-8.89
P/E
TRVI - SHORT-TERM DEBT
Short-term Debt TRVI - Trevi Therapeutics, Inc.
306 K
LAST VALUE
-77.33%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR